— Know what they know.
Not Investment Advice

STIM

Neuronetics, Inc.
1W: +3.7% 1M: +10.2% 3M: -9.1% YTD: -2.8% 1Y: -70.0% 3Y: -51.4% 5Y: -89.7%
$1.40
-0.06 (-3.78%)
After Hours: $1.52 (+0.12, +8.21%)
NASDAQ · Healthcare · Medical - Diagnostics & Research · $97.0M · Alpha Radar Neutral · Power 53
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$97.0M
52W Range0.8-5.05
Volume883,328
Avg Volume2,029,974
Beta0.94
Dividend
Analyst Ratings
5 Buy 2 Hold 0 Sell
Consensus Buy
Company Info
CEOStephen J. Furlong
Employees716
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2018-06-28
3222 Phoenixville Pike
Malvern, PA 19355
US
610 640 4202
About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
REUVERS DANIEL L. 0 2026-03-23
REUVERS DANIEL L. A-Award 1,500,000 2026-03-23
Chernett Jorey P-Purchase 169,472 $1.41 2026-03-20
Pfanstiel Steven S-Sale 16,431 $1.34 2026-03-19
Sullivan Keith J S-Sale 46,289 $1.34 2026-03-19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms